This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The specific representation of these events differed between the treatments, highlighting potential differences in sideeffect profiles that should be explored in further studies. 2017; 55(7):1998-2008. Adverse events were relatively low in both groups (2.22 percent for MBK-01 and 4.26 percent for fidaxomicin). J Clin Microbiol.
During the period from 2008 through 2020, the number of precision medicines in the US increased from 5 to 285. Cancer detection involves measurement of biomarkers, which leads to the application of targeted therapy (which targets specific cancer cells). That’s how money is saved and quality of life (QOL) is improved.
Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business. What's that even for this, back in like 2008. And how do you even do that like? Stewart Gandolf: Yeah.
Inadequate health services can have devastating consequences, especially when it comes to non-communicable diseases (NCD) , such as cardiovascular diseases, cancers and diabetes, which is the leading cause of death globally. Neville Hobson [Host]: You founded Patient Connect together with your sister Zoe Barker in 2008.
A pharmacologist by training, Rawlins was the founding chairman of health technology assessment (HTA) agency NICE , leading the organisation from its inception in 1999 until 2013, and hired Sir Andrew Dillon to become the organisation’s founding chief executive.
That was in 2008. But you’d have to have one click to the sideeffects. John Mack (PG): But the industry evolved from there and they have the sideeffects on the same page. John Mack (PG): I met with somebody for lunch it in our town, he was a vendor, I forget what product he was working on.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content